Indian J Pharm Close
 

Figure 2: Comparison of 5-year disease-free survival (DFS) and overall survival (OS) among all node positive patients, by different ypN nodal stage, lymph node ratio category (LNRC), and single LNR cut-off value. (a) DFS and ypN staging; (b) DFS and LNRC; (c) DFS and single LNR value 0.25; (d) OS and ypN staging; (e) OS and LNRC; (f) OS and single LNR value 0.25

Figure 2: Comparison of 5-year disease-free survival (DFS) and overall survival (OS) among all node positive patients, by different ypN nodal stage, lymph node ratio category (LNRC), and single LNR cut-off value. (a) DFS and ypN staging; (b) DFS and LNRC; (c) DFS and single LNR value 0.25; (d) OS and ypN staging; (e) OS and LNRC; (f) OS and single LNR value 0.25